Nootropic compound l-pyroglutamyl-d-alanine-amide restores hippocampal long-term potentiation impaired by exposure to ethanol in rats
- 1 March 1995
- journal article
- Published by Elsevier in Neuroscience Letters
- Vol. 188 (3) , 163-166
- https://doi.org/10.1016/0304-3940(95)11421-r
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Piracetam and other structurally related nootropicsBrain Research Reviews, 1994
- A synaptic model of memory: long-term potentiation in the hippocampusNature, 1993
- Aniracetam‐evoked potentiation does not interact with long‐term potentiation in the CA1 region of the hippocampusSynapse, 1992
- Effects of several cerebroprotective drugs on NMDA channel function: evaluation using Xenopus oocytes and [3H]MK-801 bindingEuropean Journal of Pharmacology: Molecular Pharmacology, 1991
- Long-term potentiation in rat hippocampus is inhibited by low concentrations of ethanolBrain Research, 1990
- Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam.The Journal of Physiology, 1990
- Rats exposed prenatally to alcohol exhibit impairment in spatial navigation testBehavioural Brain Research, 1990
- Ethanol Inhibits NMDA-Activated Ion Current in Hippocampal NeuronsScience, 1989
- Peptide analogs of pyracetam as ligands for hypothetical nootropic receptorsPharmaceutical Chemistry Journal, 1985
- Impairment of long-term potentiation in rat hippocampus following chronic ethanol treatmentBrain Research, 1984